Details for New Drug Application (NDA): 019032
✉ Email this page to a colleague
The generic ingredient in TENEX is guanfacine hydrochloride. There are seven drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
Summary for 019032
Tradename: | TENEX |
Applicant: | Promius Pharma |
Ingredient: | guanfacine hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019032
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Oct 27, 1986 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 7, 1988 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 7, 1988 | TE: | RLD: | No |
Expired US Patents for NDA 019032
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-001 | Oct 27, 1986 | ⤷ Sign Up | ⤷ Sign Up |
Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-003 | Nov 7, 1988 | ⤷ Sign Up | ⤷ Sign Up |
Promius Pharma | TENEX | guanfacine hydrochloride | TABLET;ORAL | 019032-002 | Nov 7, 1988 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription